Scalable production and preclinical validation of human cardiac organoids for myocardial repair

30 August 2026 (08:15 - 08:40)

Organised by:

Abstract

Sign in to view the resources

About the speaker

Mrs Maria Kalil

Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona (Spain)

3 More presentations in this session

Presentation thumbnail

Enhancing heart regeneration and repair after myocardial infarction through inhibition of a specific MicroRNA by targeting the IFNy-JAK-STAT pathway.

Mr M. Sumpf (DE)

Presentation thumbnail

Exercise-induced cardioprotection through sex-specific remodelling in ageing murine hearts

Mr F. Betge (Zurich, CH)

Presentation thumbnail

Investigating the role of mitophagy on the maturation of pluripotent stem cell-derived cardiomyocytes

Mr K. Cheung (Shatin, HK)

Access the full session

Session thumbnail

Cardiac regeneration and stem cell biology

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET

You may be interested in

Congress Presentation

Cardiac organoids as regenerative therapy in a preclinical model of acute myocardial infarction-Corrected version

29 August 2025

Congress Presentation

Human atrium-sized in vitro modelling of atrial fibrillation: a new experimental scale for preclinical therapeutic testing

12 April 2026

Congress Presentation

Living myocardial slices as innovative screening platform for patient specific heart failure therapies

22 May 2023

Congress Presentation

In vitro platform to model anthracycline-induced cardiotoxicity and evaluate cardioprotective agents in human -induced pluripotent stem cells-derived cardiomyocytes

20 June 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources